German automotive supplier Schaeffler has agreed to acquire Ewellix Group from investment company Triton for approx. EUR 582 million in order to boost its linear range. The invest venture capital company bought the former SKF Motion
Tags :Lenz & Staehelin
JBF Finance has announced a public tender offer for all publicly held shares of SIX listed Bobst Group, the parent company of Bobst, one of the world’s leading suppliers of substrate processing, printing and
As we announced on February, Promedical, which was acquired earlier this year by a group of investors led by SME Equity Partners and Co-Investor Partners and acting through its parent company, has acquired Lauerz-based Nizell
Gyrus Capital has acquired healthcare services business Consulcesi Group alongside its founders and management. The company is leading provider of Continuous Medical Education (CME), digital marketing, data analytics and legal services to the healthcare industry.
The European Space Agency (ESA) and the European Broadcasting Union (EBU) have signed an agreement which aims at developing solutions that leverage 5G systems in the context of media delivery technologies. The goal is to
Dufry has announced that it has entered into an agreement with the Italian company Edizione to collaborate with Autogrill to create a new integrated global travel experience. The combined company will serve more than 2.3 billion
Novartis Pharma Stein has sold a building right on part of its industry area in Stein to Lonza. The SIX-listed Lonza Group has announced that it plans to construct a large-scale, commercial drug product fill &
Forterro, a group of European ERP software and services companies, through ProConcept, has acquired the entire share capital of Clip Industrie, a Swiss-based supplier of ERP software for small to midmarket industrial product manufacturing companies
Lenz & Staehelin advised the Geneva opera, the Grand Théatre de Genève, in connection with a dispute over the sale of the Opera des Nations, a wooden structure belonging to the opera. A
ImmunOs Therapeutics has closed an oversubscribed Series B financing round totaling USD 74 million. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by new investors Mission BioCapital, GL
